新型抗炎介质消退素在肾脏病领域的应用

肾脏病与透析肾移植杂志 ›› 2013, Vol. 22 ›› Issue (3): 268-271.

新型抗炎介质消退素在肾脏病领域的应用

出版日期:2013-06-28 发布日期:2013-07-03

β-arrestin research advances in AngiotensinⅡ signal pathway

Online:2013-06-28 Published:2013-07-03

摘要/Abstract

摘要：

摘要：消退素是最近发现的具有较强抗炎作用的长链多不饱和脂肪酸衍生物家族，可分为E类消退素、D类退素、阿司匹林触发型消退素等。消退素能在肾脏组织中天然合成，外源性注射消退素D1可保护缺血再灌注诱发的肾损伤。消退素E1能有效对抗肾脏纤维化，抑制梗阻性肾病中肌成纤维细胞的增殖。研究还提示消退素对肾移植排异、内毒素相关肾损伤等具有一定治疗作用。本文就消退素在肾脏病领域的研究现状作一综述。

关键词: 关键词：消退素, 肾脏病, 抗炎

Abstract:

Abstract: Resolvins are a class of long-chain polyunsaturated fatty acid derivatives newly identified with strong anti-inflammatory biological effects. Resolvins are categorized into D series, E series as well as Aspirin-triggered resolvins. Resolvins can be synthesized naturally in kidney. Exogenous supplementation of Resolvin D1 can protect mice kidneys from ischemia reperfusion injury. By inhibiting proliferation of myofibroblasts, resolvin E1 shows therapeutic effect against renal fibrosis in obstructive nephropathy. Recent studies also reported that resolvins could mitigate lipopolysaccharide-induced kidney injury and allograft rejection in kidney transplant. The present review would summarize researches of resolvins in the field of kidney diseases.

Key words: Keywords: Resolvin, Kidney disease, Anti-inflammation

赵宇亮,杨济桥,张凌,等. 新型抗炎介质消退素在肾脏病领域的应用[J]. 肾脏病与透析肾移植杂志, 2013, 22(3): 268-271.

ZHAO Yu-liang, YANG Ji-qiao, ZHANG Ling,et al. β-arrestin research advances in AngiotensinⅡ signal pathway [J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2013, 22(3): 268-271.

[1]	渠宁, 蒋红利, 李洁, 魏丽敏, 高凡凡, 陈蕾. 慢性肾脏病大鼠基于RNA-seq的肠道转录组学分析[J]. 肾脏病与透析肾移植杂志, 2021, 30(1): 7-13.
[2]	郭志勇. 从慢性肾脏病综合诊疗的角度看草酸[J]. 肾脏病与透析肾移植杂志, 2021, 30(1): 54-.
[3]	贾岚, 魏芳, 王立华, 姜埃利. 缺氧诱导因子在急性肾损伤中的作用[J]. 肾脏病与透析肾移植杂志, 2021, 30(1): 64-68.
[4]	焦晨峰,谢红浪. 2020 KDIGO指南概要：基于循证的慢性肾脏病合并糖尿病的管理和治疗[J]. 肾脏病与透析肾移植杂志, 2020, 29(6): 542-549.
[5]	康冬,尚进,武峰,白婵,肖静,赵占正. 罗沙司他对初始透析患者肾性贫血的疗效[J]. 肾脏病与透析肾移植杂志, 2020, 29(5): 420-425.
[6]	李喆,陶磊,许书添,胡伟新,王兆峰,袁冬梅,蒋静,李世军. 慢性肾脏病继发结核病患者的临床特征及预后[J]. 肾脏病与透析肾移植杂志, 2020, 29(5): 426-432.
[7]	张明超,李丽民. 巨细胞病毒与慢性肾脏病：新机制和新见解[J]. 肾脏病与透析肾移植杂志, 2020, 29(5): 469-473.
[8]	谢文佳,熊明霞,杨俊伟. 慢性肾脏病高磷血症治疗新靶点[J]. 肾脏病与透析肾移植杂志, 2020, 29(5): 474-477.
[9]	王羽晴,朱琳,周萍. 黑龙江省单中心785例儿童肾活检病理分析（2002年～2019年）[J]. 肾脏病与透析肾移植杂志, 2020, 29(4): 323-327.
[10]	王丽慧，刘健，图迪麦麦提·麦麦提敏，等. 新疆墨玉县扎瓦乡成人肾功能状态和尿检异常流行病学调查[J]. 肾脏病与透析肾移植杂志, 2020, 29(4): 333-338.
[11]	付平,汤曦. 羟氯喹在慢性肾脏病的应用体会[J]. 肾脏病与透析肾移植杂志, 2020, 29(4): 350-351.
[12]	童玲,成水芹,陈光,等. 华氏巨球蛋白血症相关肾损害的临床病理特征[J]. 肾脏病与透析肾移植杂志, 2020, 29(3): 226-231.
[13]	朱钰钰,陶舒曼,王德光. 慢性肾脏病患者锌缺乏的研究进展[J]. 肾脏病与透析肾移植杂志, 2020, 29(3): 265-269.
[14]	张丽华，涂远茂，吴晓梅，等. 含汞化妆品相关肾病的临床病理特征及预后[J]. 肾脏病与透析肾移植杂志, 2020, 29(2): 119-124.
[15]	邢月仙,张静，王琪，等. 染色质结构与肾脏疾病遗传风险解析[J]. 肾脏病与透析肾移植杂志, 2020, 29(2): 148-152.

ISSN 1006-298X CN 32-1425/R